Options traders see further downside in builders

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Rob Koremans, CEO of Italian pharmaceutical company Recordati, weighs in on the company’s purchase of Sanofi’s rare immune disorder drug, Enjaymo. Source link

Sunil Garg of Lighthouse Canton says that Bitcoin is a currency, and while it is difficult to put a value on it, pullbacks in its price are attractive buying opportunities. Source link

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Mike Conover, Brightwave CEO and co-founder, joins ‘Fast Money’ to discuss trading AI in your portfolio and opportunity in the financial sector. 04:46 Tue, Nov 12 20246:07 PM EST Source link

CNBC’s MacKenzie Sigalos reports on the latest price moves in the crypto market. Source link

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email CNBC’s Kelli Grant outlines how you can keep your identity safe from theft or fraud and what you can do should your private information become compromised. 01:30 Mon, Jul 20 20155:00 AM EDT Source link

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Gerry Keefe, HSBC co-head of global banking, joins ‘Money Movers’ to discuss what to expect from global equity performance following Trump’s election victory, what industries tariffs will target first, and much more. Source link